Edition:
United States

Active Biotech AB (ACTI.ST)

ACTI.ST on Stockholm Stock Exchange

4.91SEK
4:46am EDT
Change (% chg)

0.09kr (+1.87%)
Prev Close
4.82kr
Open
4.85kr
Day's High
4.93kr
Day's Low
4.80kr
Volume
27,108
Avg. Vol
457,907
52-wk High
21.90kr
52-wk Low
4.17kr

Select another date:

Mon, Jun 19 2017

BRIEF-Active Biotech appoints Helen Tuvesson as new CEO

* the Board has appointed the company's current CSO Helén Tuvesson as new CEO of Active Biotech AB

BRIEF-Active Biotech: FDA grants Orphan Drug Designation for tasquinimod for multiple myeloma treatment

* Reg-Active biotech: fda grants orphan drug designation for tasquinimod for the treatment of multiple myeloma Source text for Eikon: Further company coverage: (Reporting By Anna Ringstrom)

BRIEF-Active Biotech Q4 operating loss narrows to SEK 13.5 mln

* Q4 net sales SEK 7.1 million versus SEK 5.0 million year ago

Select another date: